Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Khrishanthne Sambasivan

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 7, 2013
Hypersensitivity reactions to etoposide phosphateKhrishanthne Sambasivan, Sarah Mahmoud, Arwa Kokache, et al.
Clinical Kidney Journal|August 7, 2019
Predicting long-term renal and patient survival by clinicopathological features in elderly patients undergoing a renal biopsy in a UK cohortArunraj Navaratnarajah, Khrishanthne Sambasivan, Terry H Cook, et al.
Clinical and Translational Imaging|September 17, 2024
Is there a role for [<sup>18</sup>F]-FMISO PET to guide dose adaptive radiotherapy in head and neck cancer? A review of the literatureKhrishanthne Sambasivan, Sally F Barrington, Steve Ej Connor, et al.
Npj Imaging|August 12, 2024
[<sup>18</sup>F]FSPG-PET provides an early marker of radiotherapy response in head and neck squamous cell cancerKhrishanthne Sambasivan, Will E Tyrrell, Rizwan Farooq, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 12, 2021
TNM 8 staging is a better prognosticator than TNM 7 for patients with locally advanced oral cavity squamous cell carcinoma treated with surgery and post-operative radiotherapyKhrishanthne Sambasivan, Isabel Sassoon, Selvam Thavaraj, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 7, 2013
Hypersensitivity reactions to etoposide phosphateKhrishanthne Sambasivan, Sarah Mahmoud, Arwa Kokache, et al.
Clinical Kidney Journal|August 7, 2019
Predicting long-term renal and patient survival by clinicopathological features in elderly patients undergoing a renal biopsy in a UK cohortArunraj Navaratnarajah, Khrishanthne Sambasivan, Terry H Cook, et al.
Clinical and Translational Imaging|September 17, 2024
Is there a role for [<sup>18</sup>F]-FMISO PET to guide dose adaptive radiotherapy in head and neck cancer? A review of the literatureKhrishanthne Sambasivan, Sally F Barrington, Steve Ej Connor, et al.
Npj Imaging|August 12, 2024
[<sup>18</sup>F]FSPG-PET provides an early marker of radiotherapy response in head and neck squamous cell cancerKhrishanthne Sambasivan, Will E Tyrrell, Rizwan Farooq, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 12, 2021
TNM 8 staging is a better prognosticator than TNM 7 for patients with locally advanced oral cavity squamous cell carcinoma treated with surgery and post-operative radiotherapyKhrishanthne Sambasivan, Isabel Sassoon, Selvam Thavaraj, et al.
Pageof 1